|1.||Morgan, D W: 2 articles (05/2003 - 07/2000)|
|2.||Hanley, G: 1 article (05/2003)|
|3.||DuBois, R N: 1 article (05/2003)|
|4.||Bell, R L: 1 article (05/2003)|
|5.||Matrisian, L M: 1 article (05/2003)|
|6.||Wagenaar-Miller, R A: 1 article (05/2003)|
|7.||Shattuck-Brandt, R: 1 article (05/2003)|
|8.||Harakidas, P: 1 article (07/2000)|
|9.||Steinman, D: 1 article (07/2000)|
|10.||Davidsen, S K: 1 article (07/2000)|
|1.||Prostatic Neoplasms (Prostate Cancer)
07/15/2000 - "Administration of A-177430 resulted in a dose-dependent decrease in tumor volume as compared to a control group of animals receiving vehicle alone. "
07/15/2000 - "The maximum dose (100 mg/kg per day) of A-177430 exhibited complete arrest in tumor growth and prevented the development of macroscopic tumor metastases to lungs without exhibiting any noticeable side effects. "
07/15/2000 - "Histologic examination of primary tumors from experimental animals showed extensive tumor necrosis and decreased tumor angiogenesis as determined by factor VIII staining of primary tumors following A-177430 treatment. "
|3.||Neoplasm Metastasis (Metastasis)
|1.||Factor VIII (Coagulation Factor VIII)